1,1'-(1,4-phenylene)bis(3-tert-butylurea) | 17103-01-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1,1'-(1,4-phenylene)bis(3-tert-butylurea)
• 英文别名: 1-Tert-butyl-3-[4-(tert-butylcarbamoylamino)phenyl]urea
• CAS: 17103-01-4
• 化学式: C₁₆H₂₆N₄O₂
• 分子量: 306.408
• InChiKey: GHBMKWIHRYYWMO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  82.3
• 氢给体数：
  4
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  异氰酸叔丁酯 、 对苯二胺 在 叔丁基过氧化氢 、 四丁基溴化铵 、 特戊酸钠 、 cobalt acetylacetonate 作用下， 以 水 、 乙腈 为溶剂， 反应 1.0h， 以43%的产率得到1,1'-(1,4-phenylene)bis(3-tert-butylurea)
  参考文献：
  名称：

  超声波条件下胺催化钴（II）与胺的异氰酸酯插入反应：尿素，硫脲和氮杂环化合物的不同合成

  摘要：

  AbstractCobalt(II) acetylacetonate‐catalyzed isocyanide insertion reactions with amines utilizing tert‐butyl hydroperoxide (TBHP) as an oxidant under ultrasound conditions have been developed, which lead to the synthesis of ureas, thioureas, as well as 2‐aminobenzimidazoles, 2‐aminobenzothiazoles, and 2‐aminobenzoxazoles under the general reaction conditions in up to 96% yields, respectively. The intermediate amino methylidyneaminiums, initiated by cobalt(II) acetylacetonate‐catalyzed reactions of isocyanides with amines, could be easily trapped by different nucleophiles such as water, sulfur, and intramolecular nucleophilic functional groups. This method provides a simple, general and practical protocol for the divergent synthesis of ureas, thioureas and azaheterocycles.magnified image

  DOI：

  10.1002/adsc.201300745

文献信息

• NHE3-binding compounds and methods for inhibiting phosphate transport
  申请人：ARDELYX, INC.

  公开号：US10272079B2

  公开（公告）日：2019-04-30

  Provided are NHE3-binding and/or NHE3-modulating agents having activity as phosphate transport inhibitors, including inhibitors of phosphate transport in the gastrointestinal tract and the kidneys, and methods for their use as therapeutic or prophylactic agent.

  本文提供了具有磷酸盐转运抑制剂活性的 NHE3 结合剂和/或 NHE3 调节剂，包括胃肠道和肾脏磷酸盐转运抑制剂，以及将其用作治疗或预防剂的方法。
• Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
  申请人：ARDELYX, INC

  公开号：US10376481B2

  公开（公告）日：2019-08-13

  The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist-induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders.

  本公开内容涉及用于治疗与体液潴留或盐负荷过重相关的疾病的化合物和方法，如心力衰竭（尤其是充血性心力衰竭）、慢性肾病、终末期肾病、肝病和过氧化物酶体增殖激活受体（PPAR）γ激动剂诱导的体液潴留。本公开还涉及治疗高血压的化合物和方法。本公开还涉及治疗胃肠道疾病的化合物和方法，包括治疗或减轻与胃肠道疾病相关的疼痛。
• Urea phenyl derivatives and their use as polypropylene nucleating agents
  申请人：Ma Qinggao

  公开号：US20070117890A1

  公开（公告）日：2007-05-24

  Disclosed herein are urea phenyl derivatives of the formula: wherein each R is an independently selected hydrocarbyl group and n is 2 or 3, and their use as nucleating agents for propylene polymers.
• PHENYL TETRAHYDROISOQUINOLINE COMPOUND SUBSTITUTED WITH HETEROARYL
  申请人：TAISHO PHARMACEUTICAL CO., LTD

  公开号：US20170210736A1

  公开（公告）日：2017-07-27

  The present invention provides a compound represented by the following formula [1] or a pharmaceutically acceptable salt thereof which has an excellent NHE3 inhibitory effect: [Formula 15] A-Y  [1] wherein A represents a structure represented by the following formula [2]: wherein R 11 and R 12 each represent a halogen atom or the like, R 2 represents C 1-6 alkyl or the like, ring E represents triazole, tetrazole, pyrimidine, or the like, R 31 and R 32 each represent a hydrogen atom, C 1-6 alkyl, C 1-6 alkoxy, or the like, and W represents a single bond, the formula —NH—, the formula —O—, or the formula —CONH—, and Y represents a hydrogen atom or a structure represented by the following formula [3′]:
• METHODS FOR INHIBITING PHOSPHATE TRANSPORT
  申请人：Ardelyx, Inc.

  公开号：US20200368223A1

  公开（公告）日：2020-11-26

  The present invention relates to methods for lowering serum phosphate in a mammal comprising administering an epithelial phosphate transport inhibitor, such as an NHE3 inhibitor, in combination with a phosphate binder as well as pharmaceutical compositions comprising such epithelial phosphate transport inhibitors and phosphate binders.